Brett S. Spector
Direktor/Vorstandsmitglied bei Fesariustherapeutics, Inc.
Profil
Brett S.
Spector is currently a Director at Fesariustherapeutics, Inc. He was previously the President at SuttonBrook Capital Management LP from 2009 to 2012.
Aktive Positionen von Brett S. Spector
| Unternehmen | Position | Beginn |
|---|---|---|
Fesariustherapeutics, Inc.
 Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brett S. Spector
| Unternehmen | Position | Ende |
|---|---|---|
SuttonBrook Capital Management LP
 SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Finanzdirektor/CFO | 01.04.2012 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
SuttonBrook Capital Management LP
SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Health Technology |